Director, of the UAB Pancreatobiliary Disease Center and Chief of the Section of Hepatopancreatobiliary Disease J. Bart Rose, M.D., alongside Rogeemon Jacob, M.D., and Moh’d Khushman, M.D., discusses the major breakthroughs informing multidisciplinary pancreatic cancer care.

Pancreatic cancer is among the most difficult types to treat, but clinical researchers and oncologists, like Rose, have finally moved the needle on patient survival rates. The team of three discuss new approaches to pancreatic cancer. Join them to learn more about how targeted therapies, immunotherapies, and other novel agents are improving patient journeys and outcomes.

Click here or below to listen to the podcast.